Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Energy storage as pure as air! Interview with Ron MacDonald, Zinc8 Energy Solutions

We envision creating an industry-leading company that will supply low-cost, mass-energy storage solutions on a global scale. (Ron MacDonald) Ron MacDonald, president, CEO & director Zinc8 Energy Solutions has developed innovative battery technology that uses ...
Stephan Bogner | April 8, 2020 |

Supporting the Clean Energy Industry Through the COVID-19 Response

A Letter to the Clean Energy Industry Businesses and Employees Without doubt, Zinc8 Energy Solutions Inc. has the best possible partners to continue its path to full commercialization of its unique, patented, low-cost, long-duration energy storage system. On Apr...
Stephan Bogner | April 2, 2020 |

Can NervGen keep a lid on explosive news?

Speculation of early “evidence” of successful proof-of-concept human trials sparks stock rallies Trial volunteers taking a placebo are offered the real deal in a follow-up trial as a “reward” The company&Clo...
Knox Henderson | March 20, 2024 |

FAQ: Redefining Long-Duration Energy Storage with Zinc8 President and CEO, Ron MacDonald

Zinc8 Energy Solutions President & CEO Ron MacDonald Q. What is your current view of the energy storage market globally and what are the drivers of growth in this market? A. We are seeing an accelerating growth of renewables worldwide to solve our climate cr...
Stephan Bogner | February 19, 2020 |

Implications for Gold – 2007-9 Great Recession vs. 2020 Coronavirus Crisis

When the economic crisis hits, the first instinct is to analyze the previous catastrophes to learn what to expect from and how to handle the current calamity. So, not surprisingly, many analysts have already pointed to the 2008 global financial crisis (GFC) as the most rel...
Arkadiusz Sieron | May 25, 2020 |

Zinc8 accepted into the ACRE Cleantech Incubator Program at Urban Future Lab

The bridge to rapidly scale and transform Zinc8 into a market-driven solution for the next-generation smart grid Yesterday after market close, Zinc8 Energy Solutions Inc. announced "Acceptance into New York City’s ACRE Cleantech Incubator ...
Stephan Bogner | May 7, 2020 |

Facing Low Oil Prices, Energy Firm Reduces 2020 Capex, Guidance

The latest moves of Frontera Energy in response to depressed oil prices and its ability to endure the downturn are addressed in a CIBC report. In a March 23 research note, CIBC analyst Dave Popowich reported that Frontera Energy Corp. (FEC:TSX; FECCF:OTCMKT...
Streetwise Reports | March 27, 2020 |

Marinus Pharma Shares Open Up 41% on Phase 2 Epilepsy Trial Results

Marinus Pharmaceuticals reported positive top-line results for ganaxolone in its Phase 2 refractory status epilepticus trial with all patients achieving the primary endpoint. This morning Marinus Pharmaceuticals Inc. (MRNS:NASDAQ) , a pharmaceutical firm dedicated to...
Streetwise Reports | September 27, 2019 |

Biopharma to Test Immunity Activator in Advanced Solid Cancers

The company's plans for and approach to one of its most advanced drug candidates are discussed in an H.C. Wainwright & Co. report. In a Dec. 12 research note, H.C. Wainwright & Co. analyst Ram Selvaraju reported that BioXcel Therapeutics Inc. (BTAI:NASDAQ) plans to ...
Streetwise Reports | December 19, 2019 |

US Biopharma to Launch Phase 3 Trial in Bacterial Vaginosis

Daré Bioscience's study, its prospects and the indication's U.S. market opportunity are discussed in a ROTH Capital Partners report. In a May 15 research note, ROTH Capital Partners analyst Yasmeen Rahimi reviewed why the outlook is positive for Daré Bioscience In...
Streetwise Reports | May 21, 2020 |
1 2 3 4 5 6 7 8 9 10 ...